China Health Labs & Diagnostics Ltd. announces conference call to discuss results of the third quarter 2011
November 22 2011 - 9:00AM
PR Newswire (Canada)
TSX-V: CHO OTCQX: CHLBF www.chinahealthlabs.com Financial
Results for the Third Quarter Ended September 30, 2011 to be
Released on November 29, 2011 TORONTO, Nov. 22, 2011 /CNW/ - China
Health Labs & Diagnostics Ltd. ("China Health" or the
"Company") , is pleased to announce that it will be releasing the
results of the quarter ended September 30, 2011 on November 29,
2011 after market close, and will be hosting an investor conference
call on Wednesday, November 30, 2011 at 10:00am (Eastern Time). The
purpose of this conference call will be to provide investors with
an update of the third quarter results of the Company.
Representing China Health on the conference call will be: Mr.
Shiping (Wilson) Yao, President and Chief Executive Officer Ms.
Judyanna Chen, Chief Financial Officer Mr. Kim Oishi, Member of the
Board of Directors Mr. Chao Zhang, Vice President, Finance
Following the update, a question and answer session will be
held. To participate, the dial-in instructions are as
follows: DATE: Wednesday, November 30, 2011 TIME: 10:00am, Eastern
Time Participant Dial-InNumber(s): North America Toll-Free Dial-In
Number: 1 (888) 231-8191 For Toronto and International Callers:
1(647) 427-7450 A Taped Replay will be available from 1:00 pm
Eastern Time on November 30, 2011 to 11:59 pm Eastern Time on
December 14, 2011. Taped Replay Toll Free Number: 1.855.859.2056
Taped Replay Local Dial-in Numbers: (778) 371-8506 (416) 849-0833
(514) 807-9274 (403) 451-9481 (613) 667-0035 (902) 455-3955 Taped
Replay Password: 30217441 About China Health Labs & Diagnostics
Ltd. China Health, operating in China as the Biochem Group, is a
leading diagnostic lab solution provider for the public healthcare
industry in China. The Company develops and sells Biochem Group
branded and third-party medical diagnostic products and services to
diagnostic facilities in China. Customers include large urban
hospitals, rural hospitals, Chinese military and rescue operations,
the Beijing government and third-party distributors. In 2010, China
Health had revenues of approximately $33.7 million, and intends to
expand its business by focusing its efforts on expanding its sales
network in three areas where it provides proprietary solutions, has
limited competition and which are supported by Chinese government
policies and budgets: BK Clinlab total lab solutions for rural
hospitals and clinics, POCT solutions for military and emergency
rescue services, and food safety solutions for large cities in
China. Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release. FORWARD LOOKING INFORMATION This press
release contains forward-looking statements and information that
are based on the beliefs of management and reflect China Health's
current expectations. When used in this press release, the
words "estimate", "project", "belief", "anticipate", "intend",
"expect", "plan", "predict", "may" or "should" and the negative of
these words or such variations thereon or comparable terminology
are intended to identify forward-looking statements and
information. The forward-looking statements and information
in this press release includes information relating to the
expansion of the Company's business through its sales network in
areas where it has proprietary products, limited competition and
strong government support. The forward-looking information is
based on certain assumptions, which could change materially in the
future, including the assumption that the Company will be able to
expand its sales network and business. Such statements and
information reflect the current view of China Health with respect
to risks and uncertainties that may cause actual results to differ
materially from those contemplated in those forward-looking
statements and information. By their nature, forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or
achievements, or other future events, to be materially different
from any future results, performance or achievements expressed or
implied by such forward-looking statements. Such factors include,
among others, the risk that the Company may not be able to expand
its business as expected through its sales network in any of the
areas in which it has proprietary products, limited competition and
strong government support. China Health cautions that the
foregoing list of material factors is not exhaustive. When
relying on China Health's forward-looking statements and
information to make decisions, investors and others should
carefully consider the foregoing factors and other uncertainties
and potential events. China Health has assumed a certain
progression, which may not be realized. It has also assumed
that the material factors referred to above will not cause such
forward-looking statements and information to differ materially
from actual results or events. However, the list of these
factors is not exhaustive and is subject to change and there can be
no assurance that such assumptions will reflect the actual outcome
of such items or factors. THE FORWARD-LOOKING INFORMATION CONTAINED
IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH
AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT
TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE
IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON
THIS INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY
ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY
PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE
LAWS. CHINA HEALTH LABS & DIAGNOSTICS CONTACT: Judyanna
ChenChief Financial OfficerChina Health Labs & Diagnostics
Ltd.T: (416) 865-3351Email: jchen@chinahealthlabs.comBabak
PedramInvestor RelationsTMX Equicom GroupT: (416) 815-0700 ext.
264Email: bpedram@equicomgroup.com
Copyright
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jul 2023 to Jul 2024